The enrichment of the three signaling pathways (Fig. 2c) -- ErbB, Jak-STAT, TGF-beta -- is not surprising, but confirmatory: they have been widely discussed in the breast cancer literature (e.g.16, 40, 41). Here, EGFR is linked to breast carcinoma.